Abstract Submission

PPHA 2025 Conference - Call for Abstracts 

The PPHA 2025 Conference Organising Committee invites you to submit an abstract for a poster presentation at the PPHA 2025 Conference: "PRECISE, PROACTIVE, AND PERSONALISED – Towards Sustainable Health Systems", from 16 to 17 July 2025. Join us to showcase your research and contribute to the future of precision public health. Don’t miss this opportunity to be part of a global platform driving innovation and collaboration!

📣 Abstract Submission Deadline Extended to 30 May 2025

In response to numerous requests for an extension and growing interest in abstract submissions, we are pleased to announce that the abstract submission deadline has been extended to 30 May 2025.

🔔 Please note: Abstracts submitted before this new deadline will be included in the first round of reviews, with acceptance notifications to be released prior to 30 May. We strongly encourage authors to submit early to be considered in the initial round.

We are also pleased to confirm that the Early Bird registration rate will be honoured for all participants whose abstracts are accepted. Don’t miss the opportunity to enjoy the discounted rate!

Thank you once again for your interest and support. We look forward to receiving your submissions and welcoming you to the conference!

Key Dates

Abstract submission categories:

1. AI, Big Data and Data Science

2. Data Sharing, Ethics & Regulatory Framework

3. Population Health & Public Health Innovations

4. Policy, Implementation, and Sustainable Health Systems

General Submission Conditions:

1. Abstracts are required for all poster presentations. 

2. Abstracts must be submitted in English.

3. Abstracts must be submitted through the PPHA 2025 Conference – Abstract Submission Form.

4. Maximum two (2) abstracts with the same presenting author can be submitted. 

      Note that: The presenting author does not have to be the 1st author.

5. Abstracts must be submitted by 15 May 2025, 5pm Malaysian Time (MYT).

6. PPHA reserves the right to accept only one abstract per presenting author for poster presentation at the conference.

7. The title of your accepted abstract may be published on the conference website and in the PPHA 2025 Conference Program Book. By submitting an abstract, you consent to PPHA publishing your abstract.

Presenting Author and Registration:

1. The presenting author must register as a participant for the full conference at the latest 14 days after acceptance of an abstract.

2. Failure to register shall not be regarded as an automatic withdrawal of your abstract. Withdrawal of abstracts can only be accepted if notified in writing and subsequently confirmed by PPHA 2025 Secretariat (mum-som-ppha@monash.edu). It is only possible to withdraw an abstract within 14 days after notification on acceptance.

3. PPHA reserves the right to exclude any abstract from the scientific programme that is not followed by a participant registration.

Guidelines for Abstract Preparation:

1. The abstract word limit is max. 150 words per abstract excluding title, authors and affiliations. The PPHA 2025 Secretariat reserves the right to exclude abstracts that exceed the word limit.

2. The title should be as brief as possible but long enough to clearly indicate the nature of the study. Write the abstract title in CAPITAL LETTERS. No full stop at the end.

3. Author names should be listed in order without honorifics, with full names separated by commas. Affiliations should be listed below the author names and indicated using numbers in brackets.

4. The abstract must include the following:

   • Aim: Clearly state the purpose of the abstract.

   • Methods: Describe your selection of observations or experimental subjects clearly.

   • Results: Present your results in a logical sequence.

   • Conclusions: Emphasise new and important aspects of the study (perhaps as a discussion section) and the conclusions that are drawn from them.

   • You may submit your abstract in either unstructured or structured format. Please refer to here for an example of an abstract.

5. All abbreviations must be defined in first use. Statements such as “results will be discussed” or “data will be presented” cannot be accepted.

6. Use of brand names: For all references to products or companies, generic names must be used. Brand names may be included separately in a designated section of the submission form. Abstracts containing brand names within the main text (instead of the designated section) may be rejected. The PPHA 2025 Secretariat reserves the right to replace brand names with generic names without prior notice.

7. Abstracts will not be accepted if previously presented at a PPHA conference unless there is substantial increase in data.

Review Process:

1. All abstracts will be reviewed and evaluated by a selection panel appointed by the PPHA 2025 Conference Scientific Committee.

2. Notification of acceptance or rejection of the abstract will be sent to the submitter by 30 May 2025.

3. It is the responsibility of all submitters that all studies are performed with respect to national legislation, international legislation and ethical guidelines with regards to humans. The Scientific Committee reserves the right to reject any submitted abstract that is believed to violate these principles.

4. Please verify that your email address (submitter and presenting author) is correct as it will be used for contacting you after the review process.

5. The Scientific Committee reserves the right not to give detailed information as to why an abstract is rejected. The committee’s decisions are final, and no appeals, complaints, or requests for reconsideration will be entertained.

Contact us:

All enquiries regarding abstracts can be emailed to PPHA 2025 Secretariat at mum-som-ppha@monash.edu